Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
HC-5404 is an inhibitor of protein kinase R-like ER kinase (PERK; IC50 = 4 nM in a cell-free assay).1 It is selective for PERK over a panel of 25 kinases at 1 mM. HC-5404 reduces the levels of phosphorylated eukaryotic translation initiation factor 2α subunit (eIF2α) in HEK293 cells (IC50 = 33 nM). It reduces tumor volume in a 786-O renal cell carcinoma mouse xenograft model when administered at a dose of 30 mg/kg once or twice per day.2 HC-5404 has an additive effect on tumor growth inhibition when administered in combination with axitinib (Item No. 13813), cabozantinib (XL184; Item No. 18464), lenvatinib (Item No. 19375), or sunitinib (Item No. 13159) in a 786-O mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Discovery of 2-
2. PERK inhibition by HC-